Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)

January 5, 2017 updated by: Lin Liao
To investigate the association between metabolic syndrome (MS) and thyroid nodule(s).

Study Overview

Status

Unknown

Conditions

Detailed Description

To investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid nodule(s) or thyroid functions in euthyroid subjects. Screen for the risk factors that affect the incidence of thyroid nodule(s).

Study Type

Observational

Enrollment (Anticipated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 90 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.

Description

Inclusion Criteria:

  1. People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
  2. signed the informed consent.
  3. Have complete clinical data.

Exclusion Criteria:

  1. Patients with previous history of thyroid disease other than thyroid nodules.
  2. People with abnormal thyroid function.
  3. Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
  4. Pregnant or lactating women.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Cohorts and Interventions

Group / Cohort
The MS group
Patients with metabolic syndrome(MS).
The non-MS group
Patients without metabolic syndrome(MS).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The laboratory examinations
Time Frame: In 2013-2015
Lipids,glucose,thyroid functions
In 2013-2015

Secondary Outcome Measures

Outcome Measure
Time Frame
Blood pressure of patients in each group
Time Frame: In 2013-2015
In 2013-2015

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI of patients in each group
Time Frame: In 2013-2015
body mass index（BMI）
In 2013-2015
Age of patients in each group
Time Frame: In 2013-2015
In 2013-2015
Gender of patients in each group
Time Frame: In 2013-2015
In 2013-2015

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Lin Liao

Investigators

  • Study Chair: Lin Liao, Qianfoshan Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2017

Primary Completion (Anticipated)

November 1, 2017

Study Completion (Anticipated)

December 1, 2017

Study Registration Dates

First Submitted

December 26, 2016

First Submitted That Met QC Criteria

December 30, 2016

First Posted (Estimate)

January 4, 2017

Study Record Updates

Last Update Posted (Estimate)

January 9, 2017

Last Update Submitted That Met QC Criteria

January 5, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • qfsnfm-004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe